270 related articles for article (PubMed ID: 9464718)
1. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Berlière M; Charles A; Galant C; Donnez J
Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
[TBL] [Abstract][Full Text] [Related]
2. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
3. The potential oncogenic effect of tamoxifen on the endometrium.
Berlière M; Galant C; Donnez J
Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patients.
Cohen I; Altaras MM; Shapira J; Tepper R; Rosen DJ; Cordoba M; Zalel Y; Figer A; Yigael D; Beyth Y
Int J Gynecol Pathol; 1996 Apr; 15(2):152-7. PubMed ID: 8786205
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies.
Jeon J; Kim SE; Lee DY; Choi D
Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382
[TBL] [Abstract][Full Text] [Related]
7. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.
Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B
Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486
[TBL] [Abstract][Full Text] [Related]
8. Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.
Cohen I; Altaras MM; Shapira J; Tepper R; Cordoba M; Figer A; Zalel Y; Dror Y; Beyth Y
Gynecol Obstet Invest; 1997; 43(1):60-3. PubMed ID: 9015703
[TBL] [Abstract][Full Text] [Related]
9. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
11. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
12. The effects of tamoxifen therapy on the endometrium.
Zarbo G; Caruso G; Zammitti M; Caruso S; Zarbo R
Eur J Gynaecol Oncol; 2000; 21(1):86-8. PubMed ID: 10726629
[TBL] [Abstract][Full Text] [Related]
13. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
Hauth E; Libera H; Kimmig R; Forsting M
Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Chin J; Konje JC; Hickey M
Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
[TBL] [Abstract][Full Text] [Related]
15. Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen.
Fung MF; Reid A; Faught W; Le T; Chenier C; Verma S; Brydon E; Fung KF
Gynecol Oncol; 2003 Oct; 91(1):154-9. PubMed ID: 14529676
[TBL] [Abstract][Full Text] [Related]
16. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
Archer DF
Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
[No Abstract] [Full Text] [Related]
17. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings.
Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y
Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen and endometrial pathologies: a prospective study.
Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-induced hyperplasia of the endometrium.
Neis KJ; Brandner P; Schlenker M
Contrib Gynecol Obstet; 2000; 20():60-8. PubMed ID: 11791286
[TBL] [Abstract][Full Text] [Related]
20. [Endometrial evaluation prior to tamoxifen: preliminary results of a prospective study].
Berlière M; Galant C; Gillerot S; Charles A; Donnez J
Bull Cancer; 1998 Aug; 85(8):721-4. PubMed ID: 9754081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]